Poseida Therapeutics Cash Flow Statement 2018-2024 | PSTX

Fifteen years of historical annual cash flow statements for Poseida Therapeutics (PSTX).

Annual Data | Millions of US $ except per share data

Metric Name
Net Income/Loss
Total Depreciation And Amortization - Cash Flow
Other Non-Cash Items
Total Non-Cash Items
Change In Accounts Receivable
Change In Inventories
Change In Accounts Payable
Change In Assets/Liabilities
Total Change In Assets/Liabilities
Cash Flow From Operating Activities
Net Change In Property, Plant, And Equipment
Net Change In Intangible Assets
Net Acquisitions/Divestitures
Net Change In Short-term Investments
Net Change In Long-Term Investments
Net Change In Investments - Total
Investing Activities - Other
Cash Flow From Investing Activities
Net Long-Term Debt
Net Current Debt
Debt Issuance/Retirement Net - Total
Net Common Equity Issued/Repurchased
Net Total Equity Issued/Repurchased
Total Common And Preferred Stock Dividends Paid
Financial Activities - Other
Cash Flow From Financial Activities
Net Cash Flow
Stock-Based Compensation
Common Stock Dividends Paid
202320222021202020192018
$-123.43$-64.00$-124.97$-129.78$-86.53$-44.40
$-1.96$4.24$5.32$3.22$1.92$1.22
$19.15$19.27$-3.06$7.61$10.62$4.45
$17.18$23.52$2.26$10.82$12.54$5.67
$0.08$-9.09$0$0$0$0
$0$0$0$0$0$0
$1.04$-6.75$7.84$-4.17$1.53$1.00
$12.97$29.55$12.33$9.79$7.94$-0.29
$14.08$13.72$20.17$5.62$9.47$0.72
$-92.17$-26.77$-102.54$-113.33$-64.52$-38.01
$-3.07$-3.91$-2.62$-16.91$-5.16$-1.28
$0$0$0$0$0$0
$0$0$0$0$0$0
$42.20$-199.42$225$-187.52$-37.31$0
$0$0$0$0$0$0
$42.20$-199.42$225$-187.52$-37.31$0
$0$0$0$0$0$0
$39.13$-203.33$222$-204.43$-42.46$-1.28
$0$30.00$0$0$10.00$10.00
$0$0$0$0$0$0
$0$30.00$0$0$10.00$10.00
$16.62$76.61$2.52$210$4.71$15.20
$16.62$76.61$2.52$314$154$45.52
$0$0$0$0$0$0
$-0.49$-1.45$0$-0.33$-0.05$-1.45
$16.13$105$2.52$314$164$54.07
$-36.91$-124.95$122$-3.82$57.39$14.77
$23.13$18.93$16.70$7.22$3.05$0.98
$0$0$0$0$0$0